vs
FVCBankcorp, Inc.（FVCB）与STANDARD BIOTOOLS INC.（LAB）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是FVCBankcorp, Inc.的1.2倍（$19.6M vs $16.9M），FVCBankcorp, Inc.同比增速更快（4377.5% vs -11.5%），FVCBankcorp, Inc.自由现金流更多（$23.8M vs $-23.1M），过去两年FVCBankcorp, Inc.的营收复合增速更高（586.6% vs -12.2%）
FVCBankcorp是总部位于美国弗吉尼亚州的银行控股公司，旗下运营社区银行FVCbank，面向大西洋中部地区的中小企业、专业人士及个人客户提供存款、贷款、按揭、财富管理等各类个人及商业银行金融服务。
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
FVCB vs LAB — 直观对比
营收规模更大
LAB
是对方的1.2倍
$16.9M
营收增速更快
FVCB
高出4389.0%
-11.5%
自由现金流更多
FVCB
多$46.9M
$-23.1M
两年增速更快
FVCB
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $16.9M | $19.6M |
| 净利润 | — | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | 43.7% | -168.5% |
| 净利率 | — | -177.4% |
| 营收同比 | 4377.5% | -11.5% |
| 净利润同比 | — | -28.8% |
| 每股收益（稀释后） | $0.31 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FVCBLAB
| Q4 25 | $16.9M | — | ||
| Q3 25 | $416.0K | $19.6M | ||
| Q2 25 | $15.8M | $21.8M | ||
| Q1 25 | $382.0K | $40.8M | ||
| Q4 24 | $378.0K | — | ||
| Q3 24 | $412.0K | $22.1M | ||
| Q2 24 | $415.0K | $22.5M | ||
| Q1 24 | $359.0K | $45.5M |
净利润FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | $5.6M | $-34.7M | ||
| Q2 25 | $5.7M | $-33.5M | ||
| Q1 25 | $5.2M | $-26.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $4.7M | $-26.9M | ||
| Q2 24 | $4.2M | $-45.7M | ||
| Q1 24 | $1.3M | $-32.2M |
毛利率FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率FVCBLAB
| Q4 25 | 43.7% | — | ||
| Q3 25 | — | -168.5% | ||
| Q2 25 | 45.9% | -118.1% | ||
| Q1 25 | — | -80.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -120.9% | ||
| Q2 24 | — | -134.5% | ||
| Q1 24 | — | -132.2% |
净利率FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | 1341.1% | -177.4% | ||
| Q2 25 | 36.0% | -153.7% | ||
| Q1 25 | 1352.1% | -63.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 1133.3% | -122.0% | ||
| Q2 24 | 1001.2% | -203.3% | ||
| Q1 24 | 373.3% | -70.6% |
每股收益（稀释后）FVCBLAB
| Q4 25 | $0.31 | — | ||
| Q3 25 | $0.31 | $-0.09 | ||
| Q2 25 | $0.31 | $-0.09 | ||
| Q1 25 | $0.28 | $-0.07 | ||
| Q4 24 | $0.27 | — | ||
| Q3 24 | $0.25 | $-0.07 | ||
| Q2 24 | $0.23 | $-0.12 | ||
| Q1 24 | $0.07 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $253.6M | $399.7M |
| 总资产 | $2.3B | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $55.2M | ||
| Q2 24 | — | $55.1M | ||
| Q1 24 | — | $55.0M |
股东权益FVCBLAB
| Q4 25 | $253.6M | — | ||
| Q3 25 | $249.8M | $399.7M | ||
| Q2 25 | $243.2M | $424.5M | ||
| Q1 25 | $242.3M | $454.6M | ||
| Q4 24 | $235.4M | — | ||
| Q3 24 | $230.8M | $489.3M | ||
| Q2 24 | $226.5M | $510.3M | ||
| Q1 24 | $220.7M | $577.3M |
总资产FVCBLAB
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.3B | $539.6M | ||
| Q2 25 | $2.2B | $557.0M | ||
| Q1 25 | $2.2B | $579.6M | ||
| Q4 24 | $2.2B | — | ||
| Q3 24 | $2.3B | $681.5M | ||
| Q2 24 | $2.3B | $708.7M | ||
| Q1 24 | $2.2B | $777.7M |
负债/权益比FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.9M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | $-23.1M |
| 自由现金流率自由现金流/营收 | 140.7% | -118.1% |
| 资本支出强度资本支出/营收 | 0.3% | 4.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $40.0M | $-111.1M |
8季度趋势，按日历期对齐
经营现金流FVCBLAB
| Q4 25 | $23.9M | — | ||
| Q3 25 | $7.6M | $-22.2M | ||
| Q2 25 | $3.3M | $-20.7M | ||
| Q1 25 | $5.4M | $-30.3M | ||
| Q4 24 | $18.2M | — | ||
| Q3 24 | $4.7M | $-27.9M | ||
| Q2 24 | $1.6M | $-39.0M | ||
| Q1 24 | $7.2M | $-62.5M |
自由现金流FVCBLAB
| Q4 25 | $23.8M | — | ||
| Q3 25 | $7.6M | $-23.1M | ||
| Q2 25 | $3.3M | $-22.6M | ||
| Q1 25 | $5.4M | $-35.3M | ||
| Q4 24 | $18.1M | — | ||
| Q3 24 | $4.6M | $-30.1M | ||
| Q2 24 | $1.5M | $-41.0M | ||
| Q1 24 | $7.1M | $-63.3M |
自由现金流率FVCBLAB
| Q4 25 | 140.7% | — | ||
| Q3 25 | 1818.0% | -118.1% | ||
| Q2 25 | 20.8% | -103.6% | ||
| Q1 25 | 1413.6% | -86.6% | ||
| Q4 24 | 4786.0% | — | ||
| Q3 24 | 1121.8% | -136.4% | ||
| Q2 24 | 361.2% | -182.2% | ||
| Q1 24 | 1988.3% | -138.9% |
资本支出强度FVCBLAB
| Q4 25 | 0.3% | — | ||
| Q3 25 | 0.2% | 4.5% | ||
| Q2 25 | 0.1% | 8.7% | ||
| Q1 25 | 4.2% | 12.4% | ||
| Q4 24 | 37.3% | — | ||
| Q3 24 | 14.1% | 10.2% | ||
| Q2 24 | 12.8% | 8.6% | ||
| Q1 24 | 3.9% | 1.7% |
现金转化率FVCBLAB
| Q4 25 | — | — | ||
| Q3 25 | 1.36× | — | ||
| Q2 25 | 0.58× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.00× | — | ||
| Q2 24 | 0.37× | — | ||
| Q1 24 | 5.34× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FVCB
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
